Blog

MBMA data curation: How AI and expert meta-analysts get it right, fast

In MBMA, the data layer is the real bottleneck. See how AI and expert meta-analysts…

Matt Zierhut, PhD MBAAugust 14, 2026

Webinar

Transforming drug interaction evaluation workflows with DIDB

Ichiko Petrie, PharmDAugust 14, 2026

Blog

A model-informed approach to radioligand therapy dosing under Project Optimus

Explore how targeted radionuclide therapy dosing uses QSP, biologically effective dose (BED), and exposure-response modeling…

Hunter Stephens, PhDAugust 13, 2026

White Paper

Managing drug-drug interaction (DDI) risk for patients in clinical trials

Discover how DIDB® helps clinical teams assess drug-drug interaction risk, develop prohibited medication lists, &…

Katie Owens, PhDAugust 12, 2026

Live Events

Tailwinds for MIDD: What to Know About the Changing Regulatory Landscape

June 30, 2026 - 12:00 PM – 2:00 PM

CertaraAugust 12, 2026

Publication

Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients

Explore advances in model-informed precision dosing (MIPD) for pediatric antimicrobial therapy, including population PK modeling,…

CertaraJuly 29, 2026

Publication

Conditional activation of IL-12 through a Fibronectin-EDB dependent switch gate

See how QSP modeling guided the design of a reversible antibody switch that unmasks IL-12…

CertaraJuly 24, 2026

Poster

Assessing Cross-Version Simcyp Simulator Prediction Performance Using a Bioequivalence Framework to Support EMA Qualification

See how Simcyp Simulator V20–V24 DDI predictions were shown equivalent to the EMA-qualified V19 using…

CertaraJuly 24, 2026

Poster

A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans

See how quantitative pharmacology and PBPK modeling supported first in human dose selection for a…

CertaraJuly 20, 2026

Publication

Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data

QSP modeling reveals patient-specific factors driving CAR T-cell response and relapse in multiple myeloma, with…

CertaraJuly 20, 2026

Modeling and Simulation

MBMA data curation: How AI and expert meta-analysts get it right, fast

Transforming drug interaction evaluation workflows with DIDB

A model-informed approach to radioligand therapy dosing under Project Optimus

Managing drug-drug interaction (DDI) risk for patients in clinical trials

Tailwinds for MIDD: What to Know About the Changing Regulatory Landscape

Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients

Conditional activation of IL-12 through a Fibronectin-EDB dependent switch gate

Assessing Cross-Version Simcyp Simulator Prediction Performance Using a Bioequivalence Framework to Support EMA Qualification

A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans

Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data

Newsletter sign up

Quick links

Solutions

Contact